Evidence map›Paper›PMID 22954587›Full record

ReviewCurrent opinion in biotechnology2013

Recent progress in the metabolic engineering of alkaloids in plant systems.

Weslee S Glenn, Weerawat Runguphan, Sarah E O'Connor

Abstract readReview
In one paragraph

Review in Current opinion in biotechnology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Review
  2. Development of an efficientPlant biotechnology (Tokyo, Japan) · 2023
    Article
  3. Review
  4. Review
  5. Review
  6. CRISPR/Cas9-Mediated Genome Editing in Comfrey (Molecules (Basel, Switzerland) · 2021
    Article
  7. Review
  8. Article
  9. Tempo-Spatial Pattern of Stepharine Accumulation inInternational journal of molecular sciences · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Weslee S GlennJohn Innes Centre, Department of Biological Chemistry, Norwich Research Park, Norwich NR4 7UH, UK.
Weerawat Runguphan
Sarah E O'Connor

Funding

Early Steps in Alkaloid BiosynthesisR01GM074820 · NIGMS · UNIVERSITY OF EAST ANGLIA · PI O'CONNOR, SARAH E · 2007 to 2011
$1.5M
Biotechnology and Biological Sciences Research Council BB/J004561/1Biotechnology and Biological Sciences Research Council BB/J009091/1Biotechnology and Biological Sciences Research Council BBS/E/J/000CA489NIGMS NIH HHS GM074820NIGMS NIH HHS R01 GM074820
6 · The paper itself

Abstract

Plant alkaloids have a rich chemical ecology that has been exploited for medicinal purposes for thousands of years. Despite being highly represented within today's pharmacopoeia, relatively little is known about the biosynthesis, regulation and transport of these molecules. Understanding how nature synthesizes plant alkaloids will enhance our ability to overproduce--that is, to metabolically engineer--these medicinally useful compounds as well as new-to-nature compounds (with potentially improved bioactivity) derived from these natural scaffolds. Recent progress in the metabolic engineering of nitrogen-containing plant natural products--specifically the monoterpene indole alkaloids, the benzylisoquinoline alkaloids and the glucosinolates--was made possible through the characterization of various components in both native and engineered enzymatic pathways. The subsequent reconfiguration and tuning of these biological 'parts' has enabled the production of selected products at increasingly higher titers.

Indexed as

Metabolic EngineeringAlkaloidsBenzylisoquinolinesBiological ProductsCytochrome P-450 Enzyme SystemGlucosinolatesIndole AlkaloidsMonoterpenesPlantsAlkaloidsBenzylisoquinolinesBiological ProductsCytochrome P-450 Enzyme SystemGlucosinolatesIndole AlkaloidsMonoterpenes

Identifiers

PMID22954587
PMCPMC3552043

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.